HPV Vaccine Has Protected Thousands Of People From Cervical Cancer, According To New Study
The HPV (human papillomavirus) vaccine pledged to help protect students between the ages of 12 and 13 from cervical cancer, among other cancers. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 1, 2021 Category: Pharmaceuticals Authors: Alice Broster, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news
Single-Dose HPV Vaccination Highly Effective Single-Dose HPV Vaccination Highly Effective
Only 15% of girls globally are vaccinated against human papillomavirus (HPV), but single-dose vaccination could pave the way for much better infection control, new research suggests.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 30, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
HPV Vaccination:'Dramatic' Reduction in Cervical Cancer HPV Vaccination:'Dramatic' Reduction in Cervical Cancer
New data from England show the success of the national human papillomavirus (HPV) vaccination program in preventing cervical cancer and noninvasive precursor lesions in young women.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 4, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Older HPV vaccine cuts cervical cancer rate up to 87%, study finds
Young women who were vaccinated against human papillomavirus in their teens with an older GlaxoSmithKline product called Cervarix had up to an 87% lower risk of developing cervical cancer linked... #glaxosmithkline #thelancet (Source: Reuters: Health)
Source: Reuters: Health - November 3, 2021 Category: Consumer Health News Source Type: news
HPV vaccination lowers cervical cancer risk up to 87%, British study finds
Becoming vaccinated against the human papillomavirus reduces a woman's risk for cervical cancer up to 87%, a study published Wednesday by the Lancet found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 3, 2021 Category: Consumer Health News Source Type: news
Inovio, AstraZeneca terminate cancer vaccine partnership
MedImmune Ltd., the global biologics research and development arm of AstraZeneca (NYSE: AZN), is terminating a cancer therapy partnership it has with Inovio Pharmaceuticals.
The partnership, formed in 2015, gave MedImmune of Gaithersburg, Maryland, exclusive rights to Inovio's experimental DNA-based cancer vaccine, known as INO-3112, for cancers caused by human papillomavirus (HPV) types 16 and 18.
MedImmune renamed the new drug candidate as MED10457 after acquirin g its exclusive rights. The… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 2, 2021 Category: Pharmaceuticals Authors: John George Source Type: news
Schools Could Help More Kids Get the COVID-19 Vaccine. But History Has Some Warnings
Now that the U.S. Food and Drug Administration has authorized Pfizer-BioNTech’s vaccine for kids aged 5 to 11, the Biden Administration has signaled that it will rely on a “trusted messenger” to get information to parents and provide access to vaccines once they’re approved by the Centers for Disease Control and Prevention: schools.
As part of the plan to deliver COVID-19 vaccines to the youngest population yet, schools will again take on a role they’ve assumed during health crises throughout American history: promoting vaccination to keep kids and communities safe from infectious disease. &ld...
Source: TIME: Health - November 1, 2021 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Schools Could Help More Kids Get the COVID-19 Vaccine. But History Has Some Warnings
Now that the U.S. Food and Drug Administration has authorized Pfizer-BioNTech’s vaccine for kids aged 5 to 11, the Biden Administration has signaled that it will rely on a “trusted messenger” to get information to parents and provide access to vaccines once they’re approved by the Centers for Disease Control and Prevention: schools.
As part of the plan to deliver COVID-19 vaccines to the youngest population yet, schools will again take on a role they’ve assumed during health crises throughout American history: promoting vaccination to keep kids and communities safe from infectious disease. &ld...
Source: TIME: Science - November 1, 2021 Category: Science Authors: Tara Law Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Africa: UN Honours Henrietta Lacks, Whose Cells Transformed Medical Research Worldwide
[UN News] For the past seven decades, the cells of Henrietta Lacks, a Black American woman who died of cervical cancer, have saved countless lives, and made numerous scientific breakthroughs possible, such as the human papillomavirus and polio vaccines, drugs for HIV treatment, together with cancer and COVID-19 research. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 14, 2021 Category: African Health Source Type: news
MSD Pharmaceuticals launches gender-neutral HPV vaccine GARDASIL 9 in India
"Launching GARDASIL 9 is a crucial step towards advancing the mission of building a healthy young India by reducing the disease burden of HPV-related cancers and disease in the country," MSD India Region Managing Director Rehan A Khan said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 29, 2021 Category: Pharmaceuticals Source Type: news
Adults need to take seriously vaccines for other diseases besides covid-19 and flu
Thousands of them get sick annually from illnesses — such as pertussis, shingles, human papillomavirus and pneumonia — that could have been prevented by vaccination. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - September 6, 2021 Category: Consumer Health News Authors: Marlene Cimons Source Type: news
Teen Vaccine Coverage Mainly Remained Stable in 2020
FRIDAY, Sept. 3, 2021 -- In 2020, adolescent coverage with recommended vaccines remained stable, with increased coverage for human papillomavirus (HPV) vaccine, according to research published in the Sept. 3 issue of the U.S. Centers for Disease... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 3, 2021 Category: Pharmaceuticals Source Type: news
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020
This report describes adolescent vaccination coverage in 2020. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 2, 2021 Category: American Health Tags: Adolescent Health HPV Vaccination (Human Papillomavirus) MMWR Morbidity & Mortality Weekly Report Tetanus Vaccination Vaccines Source Type: news
Prevalence of High-Risk HPV Types Dwindled Since Vaccine Approval Prevalence of High-Risk HPV Types Dwindled Since Vaccine Approval
The human papillomavirus (HPV) vaccine has substantially reduced the prevalence of the most common high-risk HPV types, even though, in a surprise, overall HPV prevalence increased over time.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 23, 2021 Category: Consumer Health News Tags: Internal Medicine News Source Type: news
HPV vaccine has a significant impact even if all girls and boys are not vaccinated
(Tampere University) Human papillomavirus (HPV) vaccines applied in national vaccination programs protect against most cancers associated with oncogenic, high-risk (hr) HPV types. Two recent studies demonstrate the impact of gender-neutral HPV vaccination in the overall protection against hrHPV infections already with low vaccination coverage. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 11, 2021 Category: Cancer & Oncology Source Type: news
